We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies, revised Privacy Policy and Terms of Service.
You are being directed to ZacksTrade, a division of LBMZ Securities and licensed broker-dealer. ZacksTrade and Zacks.com are separate companies. The web link between the two companies is not a solicitation or offer to invest in a particular security or type of security. ZacksTrade does not endorse or adopt any particular investment strategy, any analyst opinion/rating/report or any approach to evaluating individual securities.
If you wish to go to ZacksTrade, click OK. If you do not, click Cancel.
Albemarle (ALB) Stock Sinks As Market Gains: What You Should Know
Read MoreHide Full Article
Albemarle (ALB - Free Report) closed the most recent trading day at $194.68, moving -1.03% from the previous trading session. This change lagged the S&P 500's 0.36% gain on the day. Elsewhere, the Dow gained 0.01%, while the tech-heavy Nasdaq added 1.91%.
Coming into today, shares of the specialty chemicals company had lost 22.33% in the past month. In that same time, the Basic Materials sector lost 3.1%, while the S&P 500 gained 1.24%.
Investors will be hoping for strength from Albemarle as it approaches its next earnings release. The company is expected to report EPS of $7.39, up 210.5% from the prior-year quarter. Meanwhile, our latest consensus estimate is calling for revenue of $2.74 billion, up 142.66% from the prior-year quarter.
For the full year, our Zacks Consensus Estimates are projecting earnings of $30.04 per share and revenue of $11.91 billion, which would represent changes of +36.79% and +62.72%, respectively, from the prior year.
It is also important to note the recent changes to analyst estimates for Albemarle. These revisions typically reflect the latest short-term business trends, which can change frequently. As a result, we can interpret positive estimate revisions as a good sign for the company's business outlook.
Research indicates that these estimate revisions are directly correlated with near-term share price momentum. Investors can capitalize on this by using the Zacks Rank. This model considers these estimate changes and provides a simple, actionable rating system.
The Zacks Rank system, which ranges from #1 (Strong Buy) to #5 (Strong Sell), has an impressive outside-audited track record of outperformance, with #1 stocks generating an average annual return of +25% since 1988. Within the past 30 days, our consensus EPS projection has moved 0.54% lower. Albemarle is currently sporting a Zacks Rank of #3 (Hold).
Investors should also note Albemarle's current valuation metrics, including its Forward P/E ratio of 6.55. Its industry sports an average Forward P/E of 13.71, so we one might conclude that Albemarle is trading at a discount comparatively.
We can also see that ALB currently has a PEG ratio of 0.41. The PEG ratio is similar to the widely-used P/E ratio, but this metric also takes the company's expected earnings growth rate into account. The Chemical - Diversified industry currently had an average PEG ratio of 2.13 as of yesterday's close.
The Chemical - Diversified industry is part of the Basic Materials sector. This industry currently has a Zacks Industry Rank of 204, which puts it in the bottom 20% of all 250+ industries.
The Zacks Industry Rank gauges the strength of our individual industry groups by measuring the average Zacks Rank of the individual stocks within the groups. Our research shows that the top 50% rated industries outperform the bottom half by a factor of 2 to 1.
You can find more information on all of these metrics, and much more, on Zacks.com.
See More Zacks Research for These Tickers
Normally $25 each - click below to receive one report FREE:
Image: Bigstock
Albemarle (ALB) Stock Sinks As Market Gains: What You Should Know
Albemarle (ALB - Free Report) closed the most recent trading day at $194.68, moving -1.03% from the previous trading session. This change lagged the S&P 500's 0.36% gain on the day. Elsewhere, the Dow gained 0.01%, while the tech-heavy Nasdaq added 1.91%.
Coming into today, shares of the specialty chemicals company had lost 22.33% in the past month. In that same time, the Basic Materials sector lost 3.1%, while the S&P 500 gained 1.24%.
Investors will be hoping for strength from Albemarle as it approaches its next earnings release. The company is expected to report EPS of $7.39, up 210.5% from the prior-year quarter. Meanwhile, our latest consensus estimate is calling for revenue of $2.74 billion, up 142.66% from the prior-year quarter.
For the full year, our Zacks Consensus Estimates are projecting earnings of $30.04 per share and revenue of $11.91 billion, which would represent changes of +36.79% and +62.72%, respectively, from the prior year.
It is also important to note the recent changes to analyst estimates for Albemarle. These revisions typically reflect the latest short-term business trends, which can change frequently. As a result, we can interpret positive estimate revisions as a good sign for the company's business outlook.
Research indicates that these estimate revisions are directly correlated with near-term share price momentum. Investors can capitalize on this by using the Zacks Rank. This model considers these estimate changes and provides a simple, actionable rating system.
The Zacks Rank system, which ranges from #1 (Strong Buy) to #5 (Strong Sell), has an impressive outside-audited track record of outperformance, with #1 stocks generating an average annual return of +25% since 1988. Within the past 30 days, our consensus EPS projection has moved 0.54% lower. Albemarle is currently sporting a Zacks Rank of #3 (Hold).
Investors should also note Albemarle's current valuation metrics, including its Forward P/E ratio of 6.55. Its industry sports an average Forward P/E of 13.71, so we one might conclude that Albemarle is trading at a discount comparatively.
We can also see that ALB currently has a PEG ratio of 0.41. The PEG ratio is similar to the widely-used P/E ratio, but this metric also takes the company's expected earnings growth rate into account. The Chemical - Diversified industry currently had an average PEG ratio of 2.13 as of yesterday's close.
The Chemical - Diversified industry is part of the Basic Materials sector. This industry currently has a Zacks Industry Rank of 204, which puts it in the bottom 20% of all 250+ industries.
The Zacks Industry Rank gauges the strength of our individual industry groups by measuring the average Zacks Rank of the individual stocks within the groups. Our research shows that the top 50% rated industries outperform the bottom half by a factor of 2 to 1.
You can find more information on all of these metrics, and much more, on Zacks.com.